Aim of this study is to provide specimens for establishing reference values of HE4 in an apparently healthy Chinese population using the Roche Elecsys HE4 assay tested on variety of Elecsys and cobas brand immunoassay analyzers. This reference range will be compared to population of subjects who have signs and symptoms of various benign and malignant diseases, including ovarian cancer. This reference range will also be compared to the levels of HE4 in individual subjects who have been diagnosed with ovarian cancer and are being followed longitudinally for recurrence or progression of their disease.
Study Type
OBSERVATIONAL
Enrollment
2,351
China PLA General Hospital
Beijing, China
The First Affiliated Hospital of Fujian Medical University
Fuzhou, China
Sun Yat-Sen University Cancer Center
Guangzhou, China
Shandong University Qilu Hospital
Jinan, China
Establish reference in Chinese population
Time frame: October 2012 - March 2013
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Fudan University Shanghai Cancer Center
Shanghai, China
Tianjin Cancer Hospital
Tianjin, China
Xinjiang Medical University Cancer Center
Ürümqi, China
Tongji Hospital Tongji Medical Colege of HUST
Wuhan, China
Zhongshan Hospital Xiamen University
Xiamen, China